Carotid Intima-media Thickness (IMT) and Large-vessel Atherosclerosis by Multidetector Computed Tomography (MDCT)
Association of Carotid IMT and Large-vessel Atherosclerosis by MDCT in Korean Type 2 Diabetic Patients
1 other identifier
observational
71
1 country
1
Brief Summary
The aim of this study was to investigate whether carotid IMT can predict the presence of more advanced atherosclerosis such as carotid stenosis, coronary or intracranial artery disease by MDCT and whether MDCT could be useful next step for more aggressive treatment modality in Korean type 2 diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 29, 2009
CompletedFirst Posted
Study publicly available on registry
July 30, 2009
CompletedJuly 30, 2009
July 1, 2009
July 29, 2009
July 29, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
We compared prevalence of large artery stenosis according to carotid IMT group and evaluated whether maximal IMT ≥ 1.0 mm could predict for significant CAD by MDCT.
17 months
Secondary Outcomes (1)
We performed invasive coronary angiography in some patients (N=14) and analyzed association for degrees of CAD between two angiographic methods.
17 months
Study Arms (1)
Carrotid IMT group according to maximal IMT
We defined increased IMT group as whom had maximal IMT ≥ 1.0 mm.
Eligibility Criteria
type 2 diabetic patients who had multiple cardiovascular risk factors
You may qualify if:
- Type 2 diabetic patients who had multiple cardiovascular risk factors were recruited.
- Patients who had atypical chest pain, EKG abnormality (ischemic ST-T changes or abnormal Q-wave), or history of previous cardiovascular disease were also included.
You may not qualify if:
- Acute coronary SD, serum Cr\>1.4 mg/dL, history of allergy to iodinated contrast dye were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eulji University Hospital
Seoul, 139-711, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyung Wan Min, MD., PhD.
Department of Internal Medicine, Eulji University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 29, 2009
First Posted
July 30, 2009
Study Start
April 1, 2006
Study Completion
July 1, 2007
Last Updated
July 30, 2009
Record last verified: 2009-07